MedTrace Logo

Breathing Parameter Measurements for Lung Deposition Simulation

NCT05445349 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 163

Last updated 2025-11-28

No results posted yet for this study

Summary

This study aims to simulate the deposition of aerosol drugs within the airways of asthma and COPD patients based on realistic breathing patterns measured at different pulmonology centers.

Further goal of the study is to find correlations between the amount of drug depositing in the lungs and the measured breathing parameters, as well as disease status and demographic data. The results of the study will be part of a major objective targeting the optimization and personalization of aerosol drug therapy.

Conditions

Interventions

DEVICE

Emptied dry powder inhalers (DPI) used in routine asthma and COPD therapy

The DPI inhaler devices are empty, without any active ingredient or/and carrier substances. Patients are not inhaling drug doses because of the study. They are inhaling only the type and quantity of aerosol drugs that they would inhale because of their treatment. The study does not influences the undergoing treatment by medication in any way.

Sponsors & Collaborators

  • Pest County Pulmonology Hospital

    collaborator UNKNOWN

  • University of Debrecen

    collaborator OTHER

  • St. Borbala Hospital

    collaborator OTHER_GOV

  • Medical Centre Hungarian Defence Forces

    collaborator UNKNOWN

  • Hospital of Komló

    collaborator UNKNOWN

  • St. Pantaleon Hospital in Dunaújváros

    collaborator UNKNOWN

  • Medisol Development Kft.

    lead INDUSTRY

Principal Investigators

  • Gabriella Galffy, PhD · Pest County Pulmonology Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2024-06-30
Completion
2025-06-30

Countries

  • Hungary

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05445349 on ClinicalTrials.gov